Blog – Page 5 – Clinical Trial Results

What if “watchful waiting” isn’t as safe as we once thought? Dr. Christopher Cook and Dr. C. Michael Gibson discuss: Implementing a Contemporary Operational Framework for Proactive Management of Aortic Stenosis

August 10, 2026

Sponsored by Edwards Lifesciences

Dr. Tyler De Jong and Dr. C. Michael Gibson discuss DrKumo, a digital health platform that applies artificial intelligence to remote patient monitoring, with the aim of integrating real time patient data into clinical workflows, reducing administrative burden, and supporting timely, efficient, and individualized patient management.

July 28, 2026

Disclosures: TBD

New insights into the heart-kidney connection in ATTR-CM. Dr. Jeffrey Testani and Dr. C. Michael Gibson discuss new analyses showing that acoramidis was associated with early and sustained kidney-protective effects in patients with ATTR-CM—findings that may help explain the therapy’s early cardiovascular benefits and offer new perspectives on cardiorenal health.

July 24, 2026

Supported by an independent educational grant from BridgeBio Inc.

Aortic dissection is a life-threatening emergency where every minute matters. In this interview, Dr. Firas Mussa and Dr. C. Michael Gibson discuss the key signs and symptoms clinicians should recognize, why early diagnosis is so critical, and how the IMPROVE-AD trial aims to advance the care of patients with acute aortic dissection.

July 20, 2026

Disclosures: TBD

From humble beginnings to leading one of the nation’s premier cardiovascular programs, Dr. Samin Sharma and Dr. C. Michael Gibson talk about the journey that shaped his career and what lies ahead in his new role as Chief of Cardiology at Mount Sinai.

July 6, 2026

Disclosures: TBD

Atrial fibrillation affects up to 70% of patients with ATTR-CM—but how does it impact treatment outcomes?

July 1, 2026

Dr. Brett Sperry and Dr. C. Michael Gibson discuss new findings showing that acoramidis delivered consistent clinical benefits regardless of […]

Women don’t always present with the “classic” signs of heart disease—and that can have serious consequences. Dr. Malissa Wood and Dr. C. Michael Gibson discuss the gaps in women’s cardiovascular care and why CCTA is emerging as a powerful tool for earlier, more accurate diagnosis.

June 17, 2026

Sponsored by Heartflow

When we think of CT angio we usually think of risk stratification, prevention and diagnosis.

June 11, 2026

But CT angio can also be used to plan your PCI procedures ! Dr. Evan Shlofmitz and Dr. C. Michael […]

Dr. Ahmad Masri and Dr. C Michael Gibson discuss outpatient worsening heart failure in transthyretin amyloid cardiomyopathy in the Attribute-CM trial

May 29, 2026

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.

Dr. Eugene Brailovsky and Dr. C. Michael Gibson discuss: AF Outcomes and Cardiac Conduction Abnormalities In ATTRibute-CM

May 19, 2026

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.